Nosocomial Stenotrophomonas maltophilia strain with a broad host range ability to transfer antibiotic resistance [3]

Journal of Chemotherapy

Volumn 14, Issue 6, 2002, Pages 639-

  Babalova M ^a   Blahova J ^a   Kralikova K ^a   Krčméry, Vladimir ^a   Kubonova K ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b Derer 's University Hospital Slovakia   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; DRUG HYDROLYSIS; DRUG METABOLISM; GENE TRANSFER; HOSPITAL INFECTION; HUMAN; LETTER; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; STENOTROPHOMONAS MALTOPHILIA;

EID: 12244258208     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.6.639     Document Type: Letter

References (3)

1. Mokaddas EH. Increase of carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999; 11: 28-33.
2. Babálová M, Blahová J, Lešická-Hupková M, Krčméry V, Kuboňová K. Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008. Eur J Clin Microbiol Infect Dis 1995; 14: 925-927.
3. Neu HC. Antibiotic bacterial resistance. In: Lorian, V. (ed.): Antibiotics in Laboratory Medicine (2 edition), Williams and Wilkins, Baltimore, 1986: 762-765.